Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase-Reference-Cited by-同舟云学术

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Published:2007-01-15 Issue:1 Volume:2 Page:58-61
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Pan Zhengying,Scheerens Heleen,Li Shyr-Jiann,Schultz Brian E.,Sprengeler Paul A.,Burrill L. Chuck,Mendonca Rohan V.,Sweeney Michael D.,Scott Keana C. K.,Grothaus Paul G.,Jeffery Douglas A.,Spoerke Jill M.,Honigberg Lee A.,Young Peter R.,Dalrymple Stacie A.,Palmer James T.

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference22 articles.

1. Tec kinases: modulators of lymphocyte signaling and development

2. Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement

3. Silencing of Bruton's tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA)

4. Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]

5. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

Cited by 589 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the design of small molecular drugs with acrylamides covalent warheads;Bioorganic & Medicinal Chemistry;2024-10

2. Development of ketalized unsaturated saccharides as multifunctional cysteine-targeting covalent warheads;Communications Chemistry;2024-09-09

3. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

4. Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction;Bioorganic Chemistry;2024-09

5. Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics;2024-07-25